ENPP7 and malignant colon neoplasm: Alk-SMase acts with phospholipase C to hydrolyse sphingomyelin (SM) to ceramide, inactivate platelet-activating factor (PAF) and reduce the formation of lysophosphatidic acid (LPA); these effects are all associated with the inhibition of colon cancer [1, 2].